CEO Jeremy Bender was paid $6,560,577 in fiscal year 2024, ↓ down 5.1% from fiscal year 2023 (SEC filing 0001140361-25-013462 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$6,560,577 ↓ Jeremy Bender total, FY2024 | — CEO pay percentile vs peers | 17:1 CEO-to-median pay ratio | — Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jeremy Bender | $680,000 | $0 | $2,700,280 | $2,664,697 | $501,800 | $0 | $13,800 | $6,560,577 |
| Chief Executive Officer and President | ||||||||
| Charles York | 541,000 | 0 | 1,530,640 | 1,511,240 | 299,400 | 0 | 13,800 | 3,896,080 |
| Chief Operating Officer and Chief Financial Officer | ||||||||
| Samuel Blackman | 527,000 | 0 | 1,400,680 | 1,381,724 | 291,700 | 0 | 13,800 | 3,614,904 |
| Co-Founder and Head of Research and Development | ||||||||
| Adam Dubow | 455,000 | 0 | 851,960 | 840,954 | 223,900 | 0 | 13,800 | 2,385,614 |
| General Counsel, Chief Compliance Officer and Secretary | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Jeremy Bender | $6,560,577 | $6,913,959 | $5,074,256 | ↓ −353,382 |
| Charles York | 3,896,080 | 3,546,093 | 2,307,251 | ↑ +349,987 |
| Samuel Blackman | 3,614,904 | 2,485,392 | 2,064,997 | ↑ +1,129,512 |
| Adam Dubow | 2,385,614 | 2,773,253 | — | ↓ −387,639 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Day One Biopharmaceuticals's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper DAWN reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses DAWN in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named DAWN in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2024 total |
|---|---|---|
| Daniel Becker | Former director (through FY2024) | $18,736 |
| Garry Nicholson | Chair of the Board | $363,475 |
| Habib Dable | Independent Director | $910,022 |
| John Josey | Independent Director | $332,225 |
| Michael Gladstone | Independent Director | $330,350 |
| Natalie Holles | Independent Director | $337,850 |
| Scott Garland | Independent Director | $330,350 |
| William Grossman | Independent Director | $911,897 |
Every insider equity transaction reported on Form 4 after the 2024 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 90,000 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | D | 90,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 90,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 309,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | A | 162,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2025-11-06 | D | 32,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2025-11-06 | D | 32,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2025-11-06 | A | 28,700 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | D | 162,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | D | 116,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | A | 497,667 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 4,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 4,750 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,162 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 2,250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2025-11-15 | — | 3,125 | — | — | 2 insiders, 2 accrual rows | ||
| Charles York | COO and CFO | 2025-11-15 | A | 2,250 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 1,375 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 3,570 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 2,963 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,162 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 1,750 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 2,963 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 3,570 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-17 | D | 4,062 | 9 | 36,212 | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-17 | D | 3,726 | 9 | 33,216 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-17 | D | 4,319 | 9 | 38,503 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-17 | D | 15,894 | 9 | 141,690 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | A | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | A | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 7,225 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 7,225 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-01-30 | A | 110,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-01-30 | A | 114,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-01-30 | A | 74,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-01-30 | A | 355,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-01-30 | A | 171,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-01-30 | A | 126,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-01-30 | A | 105,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-01-30 | A | 188,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-01-30 | A | 237,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-01-30 | A | 70,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 11,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 14,812 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 4,750 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 7,875 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 2,250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 7,875 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 2,250 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-02-15 | — | 1,750 | — | — | 1 insider, 1 accrual row | ||
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 3,688 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 4,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,688 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 3,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,162 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-15 | D | 7,125 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-15 | A | 7,125 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 4,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 4,375 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 1,750 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 4,375 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,162 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 14,812 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 4,625 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 11,688 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 2,963 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 2,963 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-17 | D | 5,814 | 12 | 67,448 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-17 | D | 15,459 | 12 | 179,338 | Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-17 | D | 2,728 | 12 | 31,647 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-17 | D | 6,395 | 12 | 74,188 | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-17 | D | 6,065 | 12 | 70,359 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 8,889 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 18,978 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 330,200 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 60,157 | — | — | Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 33,900 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 66,660 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 1,181 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 40,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 25,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 5,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 46,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 116,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 151,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 497,667 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 106,875 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 346,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 4,397 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 128,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 286,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 286,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 244,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 300,000 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 20,204 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 397,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 1,463,134 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 66,660 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 48,072 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 57,310 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 300,000 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 40,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 72,292 | — | — | Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 40,300 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 40,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 162,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 162,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 312,025 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 355,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 808,285 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 147,702 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 204,643 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 309,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 69,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 25,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 110,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 63,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 118,125 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 72,875 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 226,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 171,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 18,197 | — | — | Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| AI Day1 LLC | Greater-than-10% holder | 2026-04-23 | D | 12,929,322 | 22 | 277,980,423 | Common, indirect | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 81,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| AI Day1 LLC | Greater-than-10% holder | 2026-04-23 | D | 827,586 | 21 | 17,793,016 | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 47,581 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 40,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 40,485 | — | — | Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 14,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 222,188 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 65,625 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 105,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 72,694 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 188,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 6,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 90,000 | $0 | $0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | D | 90,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 90,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-06 | A | 309,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | A | 162,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2025-11-06 | D | 32,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2025-11-06 | D | 32,335 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2025-11-06 | A | 28,700 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | D | 162,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | D | 116,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-06 | A | 497,667 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 4,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 4,750 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,162 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 2,250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | D | 1,375 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 2,250 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 1,375 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 1,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 3,570 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 2,963 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-15 | D | 3,162 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 1,750 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | A | 2,963 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-15 | D | 3,570 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2025-11-17 | D | 4,062 | 9 | 36,212 | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2025-11-17 | D | 3,726 | 9 | 33,216 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2025-11-17 | D | 4,319 | 9 | 38,503 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-17 | D | 15,894 | 9 | 141,690 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | A | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | A | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 7,225 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 7,225 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2025-11-25 | D | 300,000 | 0 | 0 | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-01-30 | A | 110,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-01-30 | A | 114,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-01-30 | A | 74,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-01-30 | A | 355,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-01-30 | A | 171,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-01-30 | A | 126,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-01-30 | A | 105,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-01-30 | A | 188,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-01-30 | A | 237,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-01-30 | A | 70,000 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 11,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 11,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 14,812 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 4,750 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 7,875 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 2,250 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 7,875 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 2,250 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 1,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 3,688 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 4,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,688 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 3,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 3,687 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,162 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-15 | D | 7,125 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-15 | A | 7,125 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 4,750 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 11,687 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 4,375 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 1,750 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 4,375 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,687 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | D | 3,688 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 3,162 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | D | 14,812 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-15 | A | 4,625 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-15 | A | 11,688 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | D | 2,963 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | D | 6,625 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-15 | A | 2,963 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-15 | A | 6,625 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-02-17 | D | 5,814 | 12 | 67,448 | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-02-17 | D | 15,459 | 12 | 179,338 | Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-02-17 | D | 2,728 | 12 | 31,647 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-02-17 | D | 6,395 | 12 | 74,188 | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-02-17 | D | 6,065 | 12 | 70,359 | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 8,889 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 18,978 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 330,200 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 60,157 | — | — | Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 33,900 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 66,660 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 1,181 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 40,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 25,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 5,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 46,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 116,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 151,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 497,667 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 106,875 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 346,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 4,397 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 128,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 286,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 286,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 244,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 300,000 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 20,204 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 397,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 1,463,134 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| William Grossman | Director | 2026-04-23 | D | 66,660 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 48,072 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 57,310 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 300,000 | — | — | Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 40,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 72,292 | — | — | Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 40,300 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 40,565 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 162,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 162,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 312,025 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 355,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 808,285 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 147,702 | — | — | Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 204,643 | — | — | Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 309,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 69,375 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 25,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Lauren Merendino | Chief Commercial Officer | 2026-04-23 | D | 110,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 63,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 118,125 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 72,875 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 226,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael Vasconcelles | Head of Research and Dev. | 2026-04-23 | D | 171,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 18,197 | — | — | Common | Form 4 ↗ |
| Habib Dable | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| AI Day1 LLC | Greater-than-10% holder | 2026-04-23 | D | 12,929,322 | 22 | 277,980,423 | Common, indirect | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 81,816 | — | — | Derivative, Class A Common | Form 4 ↗ |
| AI Day1 LLC | Greater-than-10% holder | 2026-04-23 | D | 827,586 | 21 | 17,793,016 | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 32,335 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 47,581 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 40,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Natalie Holles | Director | 2026-04-23 | D | 28,700 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Saira Ramasastry | Director | 2026-04-23 | D | 40,485 | — | — | Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Scott Garland | Director | 2026-04-23 | D | 37,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Garry Nicholson | Director | 2026-04-23 | D | 15,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 14,250 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Jeremy Bender | Director | 2026-04-23 | D | 222,188 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 65,625 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 105,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 90,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Adam Dubow | Gen Counsel & Secretary | 2026-04-23 | D | 72,694 | — | — | Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 188,000 | — | — | Derivative, Class A Common | Form 4 ↗ |
| John Josey | Director | 2026-04-23 | D | 22,500 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Charles York | COO and CFO | 2026-04-23 | D | 6,750 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Charles York | OPTION | 2024-01-05 | — | — | 162,000 | — | $1,511,240 |
| Jeremy Bender | RSU | 2024-01-05 | — | — | 187,000 | — | 2,700,280 |
| Samuel Blackman | RSU | 2024-01-05 | — | — | 97,000 | — | 1,400,680 |
| Adam Dubow | RSU | 2024-01-05 | — | — | 59,000 | — | 851,960 |
| Charles York | RSU | 2024-01-05 | — | — | 106,000 | — | 1,530,640 |
| Samuel Blackman | OPTION | 2024-01-05 | — | — | 148,000 | — | 1,381,724 |
| Jeremy Bender | OPTION | 2024-01-05 | — | — | 286,000 | — | 2,664,697 |
| Adam Dubow | OPTION | 2024-01-05 | — | — | 90,000 | — | 840,954 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Charles York | $1,530,640 | $0 | $1,511,240 | 0.0% |
| Jeremy Bender | 2,700,280 | 0 | 2,664,697 | 0.0% |
| Samuel Blackman | 1,400,680 | 0 | 1,381,724 | 0.0% |
| Adam Dubow | 851,960 | 0 | 840,954 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jeremy Bender | RSU | 140,252 | — | $1,776,993 |
| Charles York | RSU | 18,000 | — | 228,060 |
| Charles York | RSU | 79,500 | — | 1,007,265 |
| Samuel Blackman | RSU | 72,752 | — | 921,768 |
| Charles York | Option | 124,875 | 14.44 | — |
| Adam Dubow | RSU | 44,252 | — | 560,673 |
| Jeremy Bender | RSU | 14,256 | — | 180,624 |
| Jeremy Bender | RSU | 38,000 | — | 481,460 |
| Charles York | RSU | 14,066 | — | 178,216 |
| Jeremy Bender | RSU | 27,260 | — | 345,384 |
| Adam Dubow | RSU | 23,702 | — | 300,304 |
| Adam Dubow | RSU | 14,000 | — | 177,380 |
| Samuel Blackman | RSU | 11,504 | — | 145,756 |
| Charles York | RSU | 5,500 | — | 69,685 |
| Jeremy Bender | Option | 220,462 | 14.44 | — |
| Samuel Blackman | RSU | 5,144 | — | 65,174 |
| Adam Dubow | Option | 46,875 | 23.41 | — |
| Samuel Blackman | RSU | 4,756 | — | 60,259 |
| Jeremy Bender | Option | 127,091 | 23.41 | — |
| Jeremy Bender | Option | 107,523 | 14.26 | — |
| Samuel Blackman | Option | 114,087 | 14.44 | — |
| Jeremy Bender | Option | 143,166 | 16 | — |
| Charles York | Option | 60,425 | 23.41 | — |
| Charles York | Option | 40,898 | 14.26 | — |
| Charles York | Option | 37,007 | 16 | — |
| Samuel Blackman | Option | 37,500 | 23.41 | — |
| Samuel Blackman | Option | 36,569 | 14.26 | — |
| Samuel Blackman | Option | 18,907 | 16 | — |
| Adam Dubow | Option | 69,375 | 14.44 | — |
| Adam Dubow | Option | 141,632 | 21.14 | — |
The objective is to hire, reward, and retain world-class talent to execute strategy and develop new medicines. Compensation is tied to performance and stock price, with the vast majority of target total direct compensation being variable and at risk (approx. 90% for CEO, 84% for other NEOs).
| CEO STI target (% of salary) | NaN% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia Inc. |
| Clawback policy | Adopted in December 2023 in compliance with SEC Rule 10D-1 and Nasdaq rules. Provides for recovery of incentive-based compensation in the event of a financial restatement. Clawback Period is defined as the three completed fiscal years immediately prior to the determination of a restatement requirement. |
| Anti-hedging | The Insider Trading Policy bars covered persons from hedging the company's securities. |
| Anti-pledging | The Insider Trading Policy bars covered persons from pledging the company's securities. |
| Ratio (CEO : median employee) | 17 : 1 |
|---|---|
| CEO total compensation | $6,560,577 |
| Median employee compensation | $389,481 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| William GrossmanIndependent · Compensation | $45,597 | — | $866,300 | — | — | $911,897 |
| Habib DableIndependent · Nominating and Corporate Governance | 43,722 | — | 866,300 | — | — | 910,022 |
| Garry NicholsonIndependent · Board Chair · Compensation · Nominating and Corporate Governance | 84,875 | — | 278,600 | — | — | 363,475 |
| Saira RamasastryIndependent · Audit (Chair) | 61,750 | — | 278,600 | — | — | 340,350 |
| Natalie HollesIndependent · Compensation (Chair) | 59,250 | — | 278,600 | — | — | 337,850 |
| John JoseyIndependent · Nominating and Corporate Governance (Chair) | 53,625 | — | 278,600 | — | — | 332,225 |
| Scott GarlandIndependent · Audit | 51,750 | — | 278,600 | — | — | 330,350 |
| Michael GladstoneIndependent · Audit · Not standing for re-election | 51,750 | — | 278,600 | — | — | 330,350 |
| Daniel BeckerIndependent · Not standing for re-election · Departed during FY | 18,736 | — | 0 | — | — | 18,736 |
| Jeremy BenderEmployee director | — | — | — | — | — | 0 |
| Annual cash retainer | $43,500 |
|---|---|
| Annual equity retainer | $312,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 10,000 / 7,500 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $471,055 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $471,055 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Day One Biopharmaceuticals | 2024 | Jeremy Bender | $680,000 | $2,700,280 | $2,664,697 | $501,800 | $6,560,577 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jeremy Bender | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Executive Compensation”. As printed: 6,560,577. Filing ↗machine: r2 · c21 · span 526324–526333 |
| 2 | Section 01, Charles York | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Executive Compensation”. As printed: 3,896,080. Filing ↗machine: r5 · c21 · span 538024–538033 |
| 3 | Section 01, Samuel Blackman | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Executive Compensation”. As printed: 3,614,904. Filing ↗machine: r8 · c21 · span 549242–549251 |
| 4 | Section 01, Adam Dubow | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Executive Compensation”. As printed: 2,385,614. Filing ↗machine: r11 · c21 · span 560991–561000 |
| 5 | Section 03, Charles York OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r6 · c27 · span 607802–607811 |
| 6 | Section 03, Jeremy Bender RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r2 · c6 · span 478973–478980 |
| 7 | Section 03, Samuel Blackman RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r4 · c6 · span 482741–482747 |
| 8 | Section 03, Adam Dubow RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t129 · r5 · c6 · span 484555–484561 |
| 9 | Section 03, Charles York RSU | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “TABLE OF CONTENTS REPORT OF THE COMPENSATION COMMITTEE” · grants of plan-based awards table. Filing ↗machine: t131 · r5 · c12 · span 536567–536576 |
| 10 | Section 03, Samuel Blackman OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r9 · c27 · span 622404–622413 |
| 11 | Section 03, Jeremy Bender OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r3 · c27 · span 592534–592543 |
| 12 | Section 03, Adam Dubow OPTION | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t138 · r12 · c27 · span 637747–637754 |
| 13 | Section 07, pay ratio | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “CEO Pay Ratio”. As printed: 17 : 1. Filing ↗ |
| 14 | Section 08, William Grossman | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 911,897. Filing ↗machine: span 252299–252525 |
| 15 | Section 08, Habib Dable | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 910,022. Filing ↗machine: span 246559–246742 |
| 16 | Section 08, Garry Nicholson | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 363,475. Filing ↗machine: span 257805–257988 |
| 17 | Section 08, Saira Ramasastry | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 340,350. Filing ↗machine: span 259723–259905 |
| 18 | Section 08, Natalie Holles | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 337,850. Filing ↗machine: span 254069–254252 |
| 19 | Section 08, John Josey | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 332,225. Filing ↗machine: span 256077–256260 |
| 20 | Section 08, Scott Garland | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 330,350. Filing ↗machine: span 248555–248738 |
| 21 | Section 08, Michael Gladstone | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 330,350. Filing ↗machine: span 250300–250483 |
| 22 | Section 08, Daniel Becker | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 18,736. Filing ↗machine: span 243650–243829 |
| 23 | Section 08, Jeremy Bender | DEF 14A | 2025-04-11 | 0001140361-25-013462 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 24 | Section 02, Adam Dubow 2025-11-06 | Form 4 | 2025-11-07 | 0001744507-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Adam Dubow 2025-11-06 | Form 4 | 2025-11-07 | 0001744507-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Adam Dubow 2025-11-06 | Form 4 | 2025-11-07 | 0001744507-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Adam Dubow 2025-11-06 | Form 4 | 2025-11-07 | 0001744507-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Charles York 2025-11-06 | Form 4 | 2025-11-07 | 0001655962-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, John Josey 2025-11-06 | Form 4 | 2025-11-07 | 0001776351-25-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Habib Dable 2025-11-06 | Form 4 | 2025-11-07 | 0001690773-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, John Josey 2025-11-06 | Form 4 | 2025-11-07 | 0001776351-25-000003 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Charles York 2025-11-06 | Form 4 | 2025-11-07 | 0001655962-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Charles York 2025-11-06 | Form 4 | 2025-11-07 | 0001655962-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Charles York 2025-11-06 | Form 4 | 2025-11-07 | 0001655962-25-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Lauren Merendino 2025-11-15 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Jeremy Bender 2025-11-15 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Adam Dubow 2025-11-15 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Charles York 2025-11-15 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Charles York 2025-11-17 | Form 4 | 2025-11-18 | 0001655962-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Lauren Merendino 2025-11-17 | Form 4 | 2025-11-18 | 0001855298-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, Adam Dubow 2025-11-17 | Form 4 | 2025-11-18 | 0001744507-25-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Jeremy Bender 2025-11-17 | Form 4 | 2025-11-18 | 0001863107-25-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Jeremy Bender 2025-11-25 | Form 4 | 2025-11-26 | 0001863107-25-000007 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Lauren Merendino 2026-01-30 | Form 4 | 2026-01-30 | 0001855298-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Michael Vasconcelles 2026-01-30 | Form 4 | 2026-01-30 | 0001734755-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Lauren Merendino 2026-01-30 | Form 4 | 2026-01-30 | 0001855298-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Jeremy Bender 2026-01-30 | Form 4 | 2026-01-30 | 0001863107-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Michael Vasconcelles 2026-01-30 | Form 4 | 2026-01-30 | 0001734755-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Charles York 2026-01-30 | Form 4 | 2026-01-30 | 0001655962-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, Adam Dubow 2026-01-30 | Form 4 | 2026-01-30 | 0001744507-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Charles York 2026-01-30 | Form 4 | 2026-01-30 | 0001655962-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Jeremy Bender 2026-01-30 | Form 4 | 2026-01-30 | 0001863107-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, Adam Dubow 2026-01-30 | Form 4 | 2026-01-30 | 0001744507-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 86 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 87 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 88 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 89 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 90 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 91 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 92 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 93 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 94 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 95 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 96 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 97 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 98 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 99 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 100 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 101 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 102 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 103 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 104 | Section 02, Michael Vasconcelles 2026-02-15 | Form 4 | 2026-02-18 | 0001734755-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 105 | Section 02, Michael Vasconcelles 2026-02-15 | Form 4 | 2026-02-18 | 0001734755-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 106 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 107 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 108 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 109 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 110 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 111 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 112 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 113 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 114 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 115 | Section 02, Lauren Merendino 2026-02-15 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 116 | Section 02, Jeremy Bender 2026-02-15 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 117 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 118 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 119 | Section 02, Adam Dubow 2026-02-15 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 120 | Section 02, Charles York 2026-02-15 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 121 | Section 02, Lauren Merendino 2026-02-17 | Form 4 | 2026-02-18 | 0001855298-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 122 | Section 02, Jeremy Bender 2026-02-17 | Form 4 | 2026-02-18 | 0001863107-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 123 | Section 02, Michael Vasconcelles 2026-02-17 | Form 4 | 2026-02-18 | 0001734755-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 124 | Section 02, Adam Dubow 2026-02-17 | Form 4 | 2026-02-18 | 0001744507-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 125 | Section 02, Charles York 2026-02-17 | Form 4 | 2026-02-18 | 0001655962-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 126 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 127 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 128 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 129 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 130 | Section 02, Garry Nicholson 2026-04-23 | Form 4 | 2026-04-23 | 0001640861-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 131 | Section 02, William Grossman 2026-04-23 | Form 4 | 2026-04-23 | 0001730229-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 132 | Section 02, William Grossman 2026-04-23 | Form 4 | 2026-04-23 | 0001730229-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 133 | Section 02, Habib Dable 2026-04-23 | Form 4 | 2026-04-23 | 0001690773-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 134 | Section 02, Habib Dable 2026-04-23 | Form 4 | 2026-04-23 | 0001690773-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 135 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 136 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 137 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 138 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 139 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 140 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 141 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 142 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 143 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 144 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 145 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 146 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 147 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 148 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 149 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 150 | Section 02, Michael Vasconcelles 2026-04-23 | Form 4 | 2026-04-23 | 0001734755-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 151 | Section 02, Michael Vasconcelles 2026-04-23 | Form 4 | 2026-04-23 | 0001734755-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 152 | Section 02, Michael Vasconcelles 2026-04-23 | Form 4 | 2026-04-23 | 0001734755-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 153 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 154 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 155 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 156 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 157 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 158 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 159 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 160 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 161 | Section 02, William Grossman 2026-04-23 | Form 4 | 2026-04-23 | 0001730229-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 162 | Section 02, William Grossman 2026-04-23 | Form 4 | 2026-04-23 | 0001730229-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 163 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 164 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 165 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 166 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 167 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 168 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 169 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 170 | Section 02, Garry Nicholson 2026-04-23 | Form 4 | 2026-04-23 | 0001640861-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 171 | Section 02, Garry Nicholson 2026-04-23 | Form 4 | 2026-04-23 | 0001640861-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 172 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 173 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 174 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 175 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 176 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 177 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 178 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 179 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 180 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 181 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 182 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 183 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 184 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 185 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 186 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 187 | Section 02, Lauren Merendino 2026-04-23 | Form 4 | 2026-04-23 | 0001855298-26-000006 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 188 | Section 02, Habib Dable 2026-04-23 | Form 4 | 2026-04-23 | 0001690773-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 189 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 190 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 191 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 192 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 193 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 194 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 195 | Section 02, Michael Vasconcelles 2026-04-23 | Form 4 | 2026-04-23 | 0001734755-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 196 | Section 02, Michael Vasconcelles 2026-04-23 | Form 4 | 2026-04-23 | 0001734755-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 197 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 198 | Section 02, Habib Dable 2026-04-23 | Form 4 | 2026-04-23 | 0001690773-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 199 | Section 02, AI Day1 LLC 2026-04-23 | Form 4 | 2026-04-27 | 0001193125-26-182440 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 200 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 201 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 202 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 203 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 204 | Section 02, AI Day1 LLC 2026-04-23 | Form 4 | 2026-04-27 | 0001193125-26-182440 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 205 | Section 02, Garry Nicholson 2026-04-23 | Form 4 | 2026-04-23 | 0001640861-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 206 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 207 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 208 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 209 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 210 | Section 02, Natalie Holles 2026-04-23 | Form 4 | 2026-04-23 | 0001580111-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 211 | Section 02, Saira Ramasastry 2026-04-23 | Form 4 | 2026-04-23 | 0001547959-26-000008 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 212 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 213 | Section 02, Scott Garland 2026-04-23 | Form 4 | 2026-04-23 | 0001533228-26-000004 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 214 | Section 02, Garry Nicholson 2026-04-23 | Form 4 | 2026-04-23 | 0001640861-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 215 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 216 | Section 02, Jeremy Bender 2026-04-23 | Form 4 | 2026-04-23 | 0001863107-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 217 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 218 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 219 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 220 | Section 02, Adam Dubow 2026-04-23 | Form 4 | 2026-04-23 | 0001744507-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 221 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 222 | Section 02, John Josey 2026-04-23 | Form 4 | 2026-04-23 | 0001776351-26-000001 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 223 | Section 02, Charles York 2026-04-23 | Form 4 | 2026-04-23 | 0001655962-26-000005 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 224 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 225 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 226 | Section 09b board cost (computed) | Computed | — | — | Cash 471,055 + equity 0 + all other 0 = 471,055, summed across the director compensation table rows.machine: formula: Σ = 471,055 |
| 227 | Day One Biopharmaceuticals (subject), Section 10b CEO total | DEF 14A | 2025-04-11 | 0001140361-25-013462 | CEO total compensation as printed in Day One Biopharmaceuticals's own proxy. As printed: 6,560,577. Filing ↗machine: r2 · c21 · span 526324–526333 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.